文献速递关节外科创伤骨科

全膝关节置换术后即使使用预防性抗凝,症状性肺栓塞发生率仍持续存在

Persistent Pulmonary Embolism Rates Following Total Knee Arthroplasty Even With Prophylactic Anticoagulants.
PubMed 文献 · J Arthroplasty · 2017-07-05

该Meta分析纳入18项多中心随机临床试验共27,073例全膝关节置换术患者,评估症状性肺栓塞发生率随时间的变化。汇总症状性肺栓塞发生率为0.37%(95%CI 0.24%-0.52%),异质性I²=66%。1996年至2010年回归分析显示肺栓塞比例无变化,95%预测区间为0.0002至0.0106。

要点

  • 全膝关节置换术后症状性肺栓塞汇总发生率为0.37%(95%CI 0.24%-0.52%),异质性I²=66%。
  • 1996年至2010年回归分析显示症状性肺栓塞比例无变化。
  • 95%预测区间为0.0002至0.0106,未来类似研究中真实比例范围为0.02%至1.06%。

核心结论

  • 在14年期间,即使患者接受强效抗凝治疗,全膝关节置换术后症状性肺栓塞发生率相对恒定。
  • 作者认为部分患者可能存在肺栓塞遗传易感性,需要开发更有效的风险分层方案以确保患者接受适当抗凝。

研究设计与样本

  • 检索MEDLINE和Cochrane对照试验中心注册库,纳入1995年1月至2016年12月间评估全膝关节置换术患者预防性抗凝的临床试验。
  • 采用随机效应模型合并各研究肺栓塞发生率,计算症状性肺栓塞汇总比例,用I²统计量量化异质性,构建95%预测区间,并用Meta回归探索时间对症状性肺栓塞发生率的影响。
  • 共纳入18项研究,代表27,073例患者。

主要发现

  • 症状性肺栓塞发生率为0.37%(95%CI 0.24%-0.52%)。
  • 研究间存在显著异质性,I²=66%。
  • 1996年至2010年间,回归分析显示肺栓塞比例无变化。
  • 95%预测区间为0.0002至0.0106,表明在未来类似研究中,症状性肺栓塞的真实比例范围为0.02%至1.06%。

临床怎么用

  • 原文结论未据此给出具体临床推荐。

局限性

  • 研究间存在显著异质性,I²=66%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Symptomatic pulmonary embolism (PE), a significant and life-threatening complication following total knee arthroplasty (TKA), has been described as a "never event." Despite a number of advancements in care, PE continues to occur following TKA. This study evaluates symptomatic PE rates over time in TKA patients enrolled in multicenter randomized clinical trials assessing the efficacy of venous thromboembolism prophylaxis regimens. METHODS: The MEDLINE and Cochrane Central Register of Controlled Trials were searched to identify clinical trials assessing prophylactic anticoagulation in patients undergoing TKA between January 1995 and December 2016. A random effect model was used to combine PE rates across studies. The pooled proportion of symptomatic PEs was calculated and heterogeneity was quantified with the I2 statistic. A 95% prediction interval was constructed to examine what the expected range in the proportion of symptomatic PEs would be in future studies. Meta-regression was used to explore the effect of time on the rate of symptomatic PEs. RESULTS: A total of 18 studies representing 27,073 patients were included in the meta-analysis. The symptomatic PE rate was 0.37% (95% confidence interval, 0.24%-0.52%). There was significant heterogeneity across studies, I2 = 66%. Between 1996 and 2010, the proportion of PEs did not change in the regression analysis. The 95% prediction interval was 0.0002 to 0.0106, indicating that in similar future studies, the true proportion of symptomatic PEs would range from 0.02% to 1.06%. CONCLUSION: Over a 14-year period, the symptomatic PE rate after TKA was relatively constant even when patients received potent anticoagulation. These results suggest that some patients may have a genetic predisposition to develop a PE and more effective risk stratification protocols need to be developed to make sure patients receive appropriate anticoagulation.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Cote MP, Chen A, Jiang Y, et al. Persistent Pulmonary Embolism Rates Following Total Knee Arthroplasty Even With Prophylactic Anticoagulants. J Arthroplasty. 2017. PMID: 28807470. doi:10.1016/j.arth.2017.06.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。